The global non-specific endonucleases market size was valued at USD 362.34 million in 2025 and is expected to reach USD 585.19 million by 2033, reflecting steady progress with a CAGR of 6.27% from 2026 to 2033. This growth trend is mainly driven by increasing investments in research and development across molecular biology and biotechnology, fields where non-specific endonucleases have become...